
News Link • Trump Administration
Trump pledges to end the use of aborted baby tissues in federal investigation.
• https://gatewayhispanic.com, Joana CamposThis decision, driven by Trump's nominee to lead the NIH, Jay Bhattacharya, and backed by key figures such as Senator Josh Hawley and Health and Human Services Secretary Robert F. Kennedy Jr., marks a milestone in the pro-life movement and the search for ethical alternatives in science.
During a hearing before the Senate Committee on Health, Education, Labor, and Pensions, Trump's NIH nominee, Jay Bhattacharya, explicitly promised to ban the use of fetal tissues from abortions in research funded by the institution.
When Senator Josh Hawley asked him if he supported Kennedy's attempt to reinstate a policy from Trump's first administration that severely restricted such investigation, Bhattacharya responded affirmatively, emphasizing that viable ethical alternatives exist.
This statement not only reaffirms Trump's commitment to pro-life values ??but also sends a clear message: science should not be based on the exploitation of innocent human lives.
The dark history of fetal tissue research .
The use of fetal tissues from abortions in scientific research has been a controversial practice for decades, funded by millions of taxpayer dollars.
During the Obama administration, for instance, millions were allocated to such research, including macabre experiments like the creation of "humanized mice" through the transplantation of aborted baby tissues into rodents.
These horrifying practices not only raise serious ethical concerns but have also been questioned for their effectiveness, as many experts argue that they have not led to significant medical breakthroughs.
Trump's first administration: An ethical precedent .
During his first term, Trump took significant steps to restrict these practices. In 2019, his administration implemented a policy that did not outright ban the use of fetal tissues but imposed strict restrictions, such as prohibiting the acquisition of new aborted fetal tissues for NIH-funded research and requiring ethical reviews by a dedicated committee.